Recorded live at AI in GxP West
How Large Enterprises Pilot AI in GxP
From idea to proof of concept: how a global pharmaceutical organization frames, tests, and governs an AI pilot inside a regulated environment, and what it takes to move one past the proof stage.
Stephen J. Cook
Senior Director, GRC CSO and Tech Operations, Global Digital & Tech, GSK
What you'll take away
- Choosing a first use case with a real owner and a measurable outcome
- The evidence a quality organization needs before a pilot is taken seriously
- The risk and accountability questions that decide whether a pilot ever scales
- Where enterprise pilots stall across IT, quality, and the business, and what separates the ones that don't
Complimentary access
Watch the full session
The full recording opens immediately. No membership, no charge.
By requesting access you agree to receive communications from KENX. Unsubscribe anytime.
Full session
On demand
No cost
Access granted
How Large Enterprises Pilot AI in GxP
Sessions like this one are what AI in GxP East is built on. Keep scrolling for 35+ more, live in Raleigh on September 15 and 16.
If you liked this session, there are 35+ more like it at
AI in GxP Singapore
Advance Pricing starting at $995, available for the first 15 registrants through 18 September
November 19 and 20, 2026 · Singapore
Where the rest of the sessions are.
Two days, 35+ case study sessions, and a faculty of practitioners who have already put AI into validated environments: governance, deviation intelligence, audit trail automation, continuous validation, and the inspection questions nobody has clean answers to yet.
Featured session · Day One
From Validation Evidence to Trust: Risk-Based Assurance for AI-Enabled GxP Systems
Giovana Mobiglia, Senior Process Validation Engineer, Pfizer
Dynamic assurance frameworks that build real confidence in AI-driven decision-making
Also on the agenda
Building a Scalable, Governable Data Estate for AI
Shawn Zheng Kai Tan, Citizen Technology Lead, Asia R&D, GSK
Ensure your data infrastructure supports GxP-grade integrity, traceability, and reuse for the agentic era
“A must-attend event for me in 2026, confirmed through the quality of the speakers and breadth of content. It answered key questions and sparked a wealth of ideas.”
AI in GxP West attendee
Speaking from inside the regulated world
Who is on the faculty.
Case studies from the quality, validation, and IT leaders accountable when AI touches a GxP system.
Gilead
SeerPharma
VTI Life Sciences
MasterControl
Pfizer
Otsuka
Novatek
INCIT
GSK
SignaMind
AIQURIS
See 35 more sessions like this one.
Singapore, November 19 & 20. Advance Pricing starting at $995
Manufacturer $995, rising to $1,195 after September 18 · Solution provider $1,195, rising to $1,395.
